Learn More
Medchemexpress LLC Cabozantinib-d6 | 1802168-46-2 | 98.1% | 1 MG

Supplier: Medchemexpress LLC HY13016S1MG
Cabozantinib-d6 is a deuterium-labeled derivative of Cabozantinib, a potent inhibitor targeting multiple receptor tyrosine kinases (RTKs) including VEGFR2, c-Met, Kit, Axl, and Flt3. This compound is designed for research applications, serving as a valuable tracer or internal standard for precise quantitative analysis methods such as NMR, GC-MS, and LC-MS.
- Deuterium-labeled compound
- Potent inhibitor of multiple receptor tyrosine kinases
- Inhibits VEGFR2, c-Met, Kit, Axl, and Flt3
- Useful as a tracer in research
- Functions as an internal standard for quantitative analysis
- Compatible with NMR, GC-MS, and LC-MS techniques
- Intended for research use only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.